GNRX
VanEck Vectors Generic Drugs ETF
GNRX
GNRX
Delisted
GNRX was delisted on the 4th of April, 2019.
2 hedge funds and large institutions have $201K invested in VanEck Vectors Generic Drugs ETF in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Jane Street
New York
|
-$271K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$259K |
| 3 |
APA
American Portfolios Advisors
Holbrook,
New York
|
-$1.96K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
APA
1
American Portfolios Advisors
Holbrook,
New York
| $177K | -$1.96K | -80 | -1% |
|
2
Bank of America
Charlotte,
North Carolina
| $24K | – | – | – |
|
|
3
Jane Street
New York
| – | -$271K | -11,145 | Closed |
|
|
4
Citadel Advisors
Miami,
Florida
| – | -$259K | -10,661 | Closed |
|